Speculatively, activation of HIF-1α could be critical for DTC to survive in these bone marrow niches or, alternatively, oxygen-independent upregulation of HIF-1α could arise from upregulation of upstream signaling pathways involved in tumor progression. Here, HIF1A is linked to neoplasm.